Article
Prediction of factor VIII inhibitor development in the SIPPET cohort by mutational analysis and factor VIII antigen measurement.
Journal of thrombosis and haemostasis : JTH - 1 Apr 2018
Spena S, Garagiola I, Cannavò A, Mortarino M, Mannucci P M, Rosendaal F R, Peyvandi F
Abstract excerpt
Essentials A residual factor VIII synthesis is likely to be protective towards inhibitor (INH) development. Mutation type-inhibitor risk association was explored in 231 patients with severe hemophilia A. A 2-fold increase in INH development for in silico null vs. non-null mutations was found. A 3.5-fold increase in INH risk for antigen negative vs. antigen positive mutations was found. SUMMARY: Background The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
